Chaim Indig has been at the helm of Phreesia, Inc. since 2005, showing a commitment to leveraging technology to improve healthcare services. His leadership style is deeply rooted in performance-based management, ensuring the company stays aligned with key metrics like...

Chaim Indig has been at the helm of Phreesia, Inc. since 2005, showing a commitment to leveraging technology to improve healthcare services. His leadership style is deeply rooted in performance-based management, ensuring the company stays aligned with key metrics like revenue growth and adjusted EBITDA. In 2023, he earned a total compensation of $1,090,564, combining a base salary of $515,000 with a bonus of $575,564 based on his team's achievements. Notably, the bonus structure reflects a strong focus on performance, with payouts heavily tied to specific financial targets. Indig's stake in Phreesia has seen fluctuations, peaking at $86.34 million in November 2021, illustrating his substantial investment in the company’s success. His employment agreement offers security, providing for a potential payout of 18 months’ salary if he were to leave under certain conditions. This not only incentivizes him but also aligns his interests with investors. Indig's background in technology is a significant advantage in steering Phreesia through the evolving landscape of healthcare.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

P

Chaim Indig

Founder and CEO of Phreesia

Education

N/A

Field of Expertise

Technology & Engineering - Technology

Sector of Economy

Healthcare

Born

January 1, 1978 - 47 years ago

CEO of Phreesia for

20 years 5 months (Jan 2005 - Present)

Previous Experience

Led the introduction of Spotfire, Inc. into pharmaceutical marketing.

Rivals

Competitors/colleagues of Chaim Indig

Holdings

See how much did Chaim Indig make over time.

Chaim Indig's investments in Phreesia highlight his deep commitment and confidence in the company's journey. Over the years, his holdings have shown significant growth, peaking at $86.34 million in November 2021, amidst a bull phase for the stock. Since then,...

Chaim Indig's investments in Phreesia highlight his deep commitment and confidence in the company's journey. Over the years, his holdings have shown significant growth, peaking at $86.34 million in November 2021, amidst a bull phase for the stock. Since then, the value has fluctuated, reaching around $54.98 million in February 2023, before dropping roughly to $23 million by November 2024. The ups and downs illustrate the fast-paced nature of the tech and health sectors, yet Indig's continued position as CEO tells us he's in it for the long haul. His decisions are clearly influenced by the company's performance, and his engagement in insider trading is limited, indicating a stable long-term perspective rather than short-term profit-seeking. This pattern of investments suggests a strategic approach—having skin in the game and believing in sustained growth for Phreesia in the healthcare landscape.

Mar 18, 2025

P

shares

PHR @ $27.27

Total Stock Sold

$32.02M

PHR

$32.02M

710,337 PHR shares

What if they kept their stock?

If Chaim Indig didn't sell their stock, today they would have:
Extra PHR710,337 shares worth $20.62M.
This is -35.59% and $11.39M less than what they got when they sold the stock.

Charitable Transactions

PHR

255,000 shares

PHR

Recent Charitable Transactions

PHR

255,000 shares

PHR

Dec 31, 2021

Charity

Insider Trading

See recent insider trades of Chaim Indig.

PHR

$1.45M

PHR at $27.67/share

Jan 27, 2025

Sale

PHR

97,820 shares

PHR

Jan 23, 2025

Received

PHR

$1.18M

PHR at $27.31/share

Jan 21, 2025

Sale

PHR

$161.35K

PHR at $26.98/share

Jan 15, 2025

Sale

PHR

$286.01K

PHR at $26.61/share

Jan 6, 2025

Sale

PHR

93,896 shares

PHR

Jan 2, 2025

Received

PHR

$123.11K

PHR at $23.25/share

Sep 10, 2024

Sale

PHR

9,670 shares

PHR

Sep 6, 2024

Received

PHR

$173.25

PHR at $24.75/share

Jul 29, 2024

Sale

PHR

$62.76K

PHR at $23.74/share

Jul 16, 2024

Sale

Compensation History

See how much did Chaim Indig make over time.

In terms of compensation, Chaim Indig received a total of $1,090,564 for 2023. This includes a base salary of $515,000 and a bonus of $575,564 linked to the company’s performance. His bonus structure is designed to reward achievement of set goals, like revenue and profitability targets, which he met at a combined rate of 117.6% during the fiscal year. This performance pay model aligns well with Phreesia’s corporate ambitions—pushing for growth while motivating executives to deliver results. Chaim's compensation has steadily increased over the years from $350,000 in 2020 to over a million in 2023, reflecting the company’s expanding influence in healthcare. Interestingly, he received no stock grants or options, reinforcing the idea that his current pay structure is heavily reliant on actual performance, not just promised equity.

Year

2023

Total Compensation

$1.09M

Salary

$515.00K

Board Justification

The compensation philosophy is designed to attract, motivate, and retain executives while aligning their interests with those of shareholders through performance-based compensation.

Bonus

$575.56K

Board Justification

The bonus is based on the achievement of predetermined Company performance targets, including revenue and Adjusted EBITDA, with a payout of 134.8% for the first half of the fiscal year and 110.2% for the full fiscal year, resulting in a total weighted average payout of 117.6%.

Other

$0.00

Board Justification

No additional compensation was reported outside of salary and bonus for 2023.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock was vested in 2023 as the focus is on performance-based stock units that vest based on future performance metrics.

Performance Metrics

The performance metrics include revenue growth and Adjusted EBITDA targets.